Eritrea
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 4.32 (3.47 - 5.21) | 2019 | Modelled | IHME |
| 4.32 (3.48 - 5.20) | 2018 | Modelled | IHME |
| 4.33 (3.47 - 5.26) | 2017 | Modelled | IHME |
| 4.68 (3.80 - 5.71) | 2016 | Modelled | IHME |
| 5.13 (4.16 - 6.28) | 2015 | Modelled | IHME |
| 5.31 (4.29 - 6.47) | 2014 | Modelled | IHME |
| 5.45 (4.39 - 6.58) | 2013 | Modelled | IHME |
| 5.57 (4.45 - 6.69) | 2012 | Modelled | IHME |
| 5.67 (4.54 - 6.84) | 2011 | Modelled | IHME |
| 5.79 (4.59 - 7.04) | 2010 | Modelled | IHME |
| 5.92 (4.74 - 7.18) | 2009 | Modelled | IHME |
| 6.04 (4.83 - 7.33) | 2008 | Modelled | IHME |
| 6.17 (4.95 - 7.48) | 2007 | Modelled | IHME |
| 6.3 (5.05 - 7.70) | 2006 | Modelled | IHME |
| 6.43 (5.15 - 7.90) | 2005 | Modelled | IHME |
| 6.58 (5.28 - 8.05) | 2004 | Modelled | IHME |
| 6.75 (5.39 - 8.20) | 2003 | Modelled | IHME |
| 6.92 (5.54 - 8.39) | 2002 | Modelled | IHME |
| 7.07 (5.63 - 8.60) | 2001 | Modelled | IHME |
| 7.21 (5.71 - 8.84) | 2000 | Modelled | IHME |
| 7.33 (5.79 - 8.99) | 1999 | Modelled | IHME |
| 7.45 (5.90 - 9.18) | 1998 | Modelled | IHME |
| 7.55 (5.99 - 9.30) | 1997 | Modelled | IHME |
| 7.64 (6.02 - 9.49) | 1996 | Modelled | IHME |
| 7.71 (6.08 - 9.62) | 1995 | Modelled | IHME |
| 7.76 (6.14 - 9.54) | 1994 | Modelled | IHME |
| 7.8 (6.14 - 9.52) | 1993 | Modelled | IHME |
| 7.84 (6.15 - 9.57) | 1992 | Modelled | IHME |
| 7.87 (6.21 - 9.54) | 1991 | Modelled | IHME |
| 7.88 (6.21 - 9.53) | 1990 | Modelled | IHME |
| 1.85 (1.49 - 2.27) | 2015 | Modelled | WHO |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.42 (0.29 - 0.57) | 2019 | Modelled | IHME |
| 0.45 (0.32 - 0.61) | 2018 | Modelled | IHME |
| 0.47 (0.33 - 0.64) | 2017 | Modelled | IHME |
| 0.5 (0.35 - 0.66) | 2016 | Modelled | IHME |
| 0.51 (0.37 - 0.69) | 2015 | Modelled | IHME |
| 0.53 (0.38 - 0.72) | 2014 | Modelled | IHME |
| 0.55 (0.39 - 0.74) | 2013 | Modelled | IHME |
| 0.56 (0.40 - 0.76) | 2012 | Modelled | IHME |
| 0.58 (0.40 - 0.78) | 2011 | Modelled | IHME |
| 0.59 (0.41 - 0.80) | 2010 | Modelled | IHME |
| 0.59 (0.41 - 0.80) | 2009 | Modelled | IHME |
| 0.6 (0.42 - 0.81) | 2008 | Modelled | IHME |
| 0.6 (0.43 - 0.81) | 2007 | Modelled | IHME |
| 0.61 (0.43 - 0.82) | 2006 | Modelled | IHME |
| 0.62 (0.44 - 0.83) | 2005 | Modelled | IHME |
| 1.01 (0.73 - 1.33) | 2004 | Modelled | IHME |
| 1.93 (1.40 - 2.52) | 2003 | Modelled | IHME |
| 3.04 (2.21 - 3.99) | 2002 | Modelled | IHME |
| 4.01 (2.90 - 5.27) | 2001 | Modelled | IHME |
| 4.51 (3.23 - 6.03) | 2000 | Modelled | IHME |
| 4.64 (3.32 - 6.18) | 1999 | Modelled | IHME |
| 4.73 (3.40 - 6.33) | 1998 | Modelled | IHME |
| 4.81 (3.45 - 6.44) | 1997 | Modelled | IHME |
| 4.86 (3.46 - 6.57) | 1996 | Modelled | IHME |
| 4.9 (3.50 - 6.68) | 1995 | Modelled | IHME |
| 4.94 (3.56 - 6.66) | 1994 | Modelled | IHME |
| 4.98 (3.59 - 6.61) | 1993 | Modelled | IHME |
| 5 (3.62 - 6.61) | 1992 | Modelled | IHME |
| 5.03 (3.68 - 6.64) | 1991 | Modelled | IHME |
| 5.04 (3.71 - 6.71) | 1990 | Modelled | IHME |
| 0.74 (0.49 - 1.05) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 236,488 (186,406 - 285,981) | 1990 | Modelled | IHME |
| 232,726 (183,631 - 282,163) | 1991 | Modelled | IHME |
| 243,471 (190,956 - 297,207) | 1992 | Modelled | IHME |
| 255,552 (201,014 - 311,873) | 1993 | Modelled | IHME |
| 266,797 (211,138 - 328,315) | 1994 | Modelled | IHME |
| 275,495 (217,464 - 343,787) | 1995 | Modelled | IHME |
| 281,378 (221,725 - 349,343) | 1996 | Modelled | IHME |
| 286,186 (226,908 - 352,457) | 1997 | Modelled | IHME |
| 289,168 (229,201 - 356,430) | 1998 | Modelled | IHME |
| 291,060 (229,941 - 357,197) | 1999 | Modelled | IHME |
| 295,382 (234,064 - 362,065) | 2000 | Modelled | IHME |
| 303,797 (241,838 - 369,472) | 2001 | Modelled | IHME |
| 313,200 (250,707 - 380,131) | 2002 | Modelled | IHME |
| 317,860 (253,950 - 386,203) | 2003 | Modelled | IHME |
| 318,831 (255,561 - 389,724) | 2004 | Modelled | IHME |
| 319,972 (256,104 - 393,041) | 2005 | Modelled | IHME |
| 321,770 (257,916 - 393,484) | 2006 | Modelled | IHME |
| 324,168 (260,066 - 393,189) | 2007 | Modelled | IHME |
| 326,048 (260,756 - 395,351) | 2008 | Modelled | IHME |
| 327,123 (261,794 - 397,120) | 2009 | Modelled | IHME |
| 327,274 (259,712 - 398,203) | 2010 | Modelled | IHME |
| 327,320 (261,873 - 394,694) | 2011 | Modelled | IHME |
| 327,250 (261,545 - 393,143) | 2012 | Modelled | IHME |
| 325,671 (262,309 - 393,021) | 2013 | Modelled | IHME |
| 322,322 (260,257 - 392,596) | 2014 | Modelled | IHME |
| 316,395 (256,551 - 387,440) | 2015 | Modelled | IHME |
| 293,889 (238,746 - 358,368) | 2016 | Modelled | IHME |
| 277,580 (222,126 - 337,102) | 2017 | Modelled | IHME |
| 283,370 (228,157 - 340,644) | 2018 | Modelled | IHME |
| 290,106 (233,157 - 349,521) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 4.58 (2.88 - 6.86) | 2019 | Modelled | IHME |
| 4.56 (2.85 - 6.90) | 2018 | Modelled | IHME |
| 4.54 (2.83 - 6.88) | 2017 | Modelled | IHME |
| 4.5 (2.78 - 6.86) | 2016 | Modelled | IHME |
| 4.5 (2.82 - 6.86) | 2015 | Modelled | IHME |
| 4.71 (2.87 - 7.15) | 2014 | Modelled | IHME |
| 5.23 (3.25 - 7.97) | 2013 | Modelled | IHME |
| 5.8 (3.58 - 8.83) | 2012 | Modelled | IHME |
| 6.27 (3.86 - 9.56) | 2011 | Modelled | IHME |
| 6.51 (4.03 - 9.96) | 2010 | Modelled | IHME |
| 6.52 (4.06 - 9.94) | 2009 | Modelled | IHME |
| 6.5 (4.02 - 9.84) | 2008 | Modelled | IHME |
| 6.45 (3.90 - 9.77) | 2007 | Modelled | IHME |
| 6.46 (3.89 - 9.82) | 2006 | Modelled | IHME |
| 6.45 (3.89 - 9.86) | 2005 | Modelled | IHME |
| 6.47 (3.88 - 9.91) | 2004 | Modelled | IHME |
| 6.47 (3.95 - 9.92) | 2003 | Modelled | IHME |
| 6.56 (4 - 9.97) | 2002 | Modelled | IHME |
| 6.51 (3.98 - 9.88) | 2001 | Modelled | IHME |
| 6.68 (4.10 - 10) | 2000 | Modelled | IHME |
| 6.63 (4.08 - 9.89) | 1999 | Modelled | IHME |
| 6.53 (4.07 - 9.76) | 1998 | Modelled | IHME |
| 6.59 (4.10 - 9.85) | 1997 | Modelled | IHME |
| 6.57 (4.03 - 9.96) | 1996 | Modelled | IHME |
| 6.58 (4.03 - 10.10) | 1995 | Modelled | IHME |
| 6.27 (3.88 - 9.46) | 1994 | Modelled | IHME |
| 6.12 (3.76 - 9.28) | 1993 | Modelled | IHME |
| 6.09 (3.74 - 9.25) | 1992 | Modelled | IHME |
| 6.09 (3.69 - 9.53) | 1991 | Modelled | IHME |
| 6.02 (3.61 - 9.36) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 307 (193 - 460) | 2019 | Modelled | IHME |
| 299 (187 - 453) | 2018 | Modelled | IHME |
| 291 (181 - 441) | 2017 | Modelled | IHME |
| 282 (174 - 431) | 2016 | Modelled | IHME |
| 277 (174 - 423) | 2015 | Modelled | IHME |
| 285 (174 - 434) | 2014 | Modelled | IHME |
| 313 (194 - 476) | 2013 | Modelled | IHME |
| 341 (210 - 519) | 2012 | Modelled | IHME |
| 362 (223 - 552) | 2011 | Modelled | IHME |
| 368 (228 - 563) | 2010 | Modelled | IHME |
| 360 (225 - 550) | 2009 | Modelled | IHME |
| 351 (217 - 531) | 2008 | Modelled | IHME |
| 339 (205 - 513) | 2007 | Modelled | IHME |
| 330 (199 - 502) | 2006 | Modelled | IHME |
| 321 (194 - 490) | 2005 | Modelled | IHME |
| 313 (188 - 480) | 2004 | Modelled | IHME |
| 305 (186 - 467) | 2003 | Modelled | IHME |
| 297 (181 - 452) | 2002 | Modelled | IHME |
| 280 (171 - 425) | 2001 | Modelled | IHME |
| 274 (168 - 411) | 2000 | Modelled | IHME |
| 263 (162 - 393) | 1999 | Modelled | IHME |
| 254 (158 - 379) | 1998 | Modelled | IHME |
| 250 (155 - 373) | 1997 | Modelled | IHME |
| 242 (148 - 367) | 1996 | Modelled | IHME |
| 235 (144 - 362) | 1995 | Modelled | IHME |
| 216 (133 - 325) | 1994 | Modelled | IHME |
| 201 (123 - 304) | 1993 | Modelled | IHME |
| 189 (116 - 287) | 1992 | Modelled | IHME |
| 180 (109 - 282) | 1991 | Modelled | IHME |
| 181 (108 - 281) | 1990 | Modelled | IHME |
| 371 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 32 (25 - 40) | 2019 | Modelled | IHME |
| 32 (25 - 41) | 2018 | Modelled | IHME |
| 32 (25 - 40) | 2017 | Modelled | IHME |
| 32 (24 - 40) | 2016 | Modelled | IHME |
| 32 (24 - 41) | 2015 | Modelled | IHME |
| 32 (25 - 41) | 2014 | Modelled | IHME |
| 32 (25 - 41) | 2013 | Modelled | IHME |
| 33 (25 - 42) | 2012 | Modelled | IHME |
| 33 (26 - 42) | 2011 | Modelled | IHME |
| 33 (26 - 42) | 2010 | Modelled | IHME |
| 33 (26 - 43) | 2009 | Modelled | IHME |
| 33 (26 - 43) | 2008 | Modelled | IHME |
| 33 (26 - 43) | 2007 | Modelled | IHME |
| 33 (26 - 43) | 2006 | Modelled | IHME |
| 33 (26 - 42) | 2005 | Modelled | IHME |
| 33 (26 - 43) | 2004 | Modelled | IHME |
| 34 (26 - 43) | 2003 | Modelled | IHME |
| 34 (26 - 43) | 2002 | Modelled | IHME |
| 34 (26 - 43) | 2001 | Modelled | IHME |
| 34 (27 - 44) | 2000 | Modelled | IHME |
| 34 (27 - 44) | 1999 | Modelled | IHME |
| 34 (27 - 44) | 1998 | Modelled | IHME |
| 35 (27 - 45) | 1997 | Modelled | IHME |
| 35 (27 - 45) | 1996 | Modelled | IHME |
| 35 (27 - 45) | 1995 | Modelled | IHME |
| 35 (27 - 45) | 1994 | Modelled | IHME |
| 35 (27 - 45) | 1993 | Modelled | IHME |
| 35 (27 - 45) | 1992 | Modelled | IHME |
| 35 (27 - 45) | 1991 | Modelled | IHME |
| 35 (27 - 45) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 95 | 2018 | Survey/reported | WHO/UNICEF |
| 95 | 2017 | Survey/reported | WHO/UNICEF |
| 95 | 2016 | Survey/reported | WHO/UNICEF |
| 95 | 2015 | Survey/reported | WHO/UNICEF |
| 94 | 2014 | Survey/reported | WHO/UNICEF |
| 94 | 2013 | Survey/reported | WHO/UNICEF |
| 94 | 2012 | Survey/reported | WHO/UNICEF |
| 94 | 2011 | Survey/reported | WHO/UNICEF |
| 95 | 2010 | Survey/reported | WHO/UNICEF |
| 95 | 2009 | Survey/reported | WHO/UNICEF |
| 95 | 2008 | Survey/reported | WHO/UNICEF |
| 95 | 2007 | Survey/reported | WHO/UNICEF |
| 94 | 2006 | Survey/reported | WHO/UNICEF |
| 96 | 2005 | Survey/reported | WHO/UNICEF |
| 84 | 2004 | Survey/reported | WHO/UNICEF |
| 91 | 2003 | Survey/reported | WHO/UNICEF |
| 86 | 2002 | Survey/reported | WHO/UNICEF |
| 95 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.7 (1.36 - 2.14) | 2019 | Modelled | IHME |
| 1.7 (1.36 - 2.13) | 2018 | Modelled | IHME |
| 1.7 (1.36 - 2.12) | 2017 | Modelled | IHME |
| 1.69 (1.36 - 2.11) | 2016 | Modelled | IHME |
| 1.68 (1.35 - 2.08) | 2015 | Modelled | IHME |
| 1.68 (1.35 - 2.09) | 2014 | Modelled | IHME |
| 1.68 (1.35 - 2.10) | 2013 | Modelled | IHME |
| 1.68 (1.35 - 2.10) | 2012 | Modelled | IHME |
| 1.68 (1.35 - 2.10) | 2011 | Modelled | IHME |
| 1.68 (1.34 - 2.11) | 2010 | Modelled | IHME |
| 1.68 (1.35 - 2.10) | 2009 | Modelled | IHME |
| 1.67 (1.35 - 2.09) | 2008 | Modelled | IHME |
| 1.67 (1.35 - 2.09) | 2007 | Modelled | IHME |
| 1.66 (1.34 - 2.09) | 2006 | Modelled | IHME |
| 1.66 (1.33 - 2.08) | 2005 | Modelled | IHME |
| 1.66 (1.34 - 2.08) | 2004 | Modelled | IHME |
| 1.67 (1.34 - 2.08) | 2003 | Modelled | IHME |
| 1.67 (1.35 - 2.07) | 2002 | Modelled | IHME |
| 1.68 (1.35 - 2.08) | 2001 | Modelled | IHME |
| 1.68 (1.35 - 2.09) | 2000 | Modelled | IHME |
| 1.69 (1.36 - 2.10) | 1999 | Modelled | IHME |
| 1.69 (1.36 - 2.11) | 1998 | Modelled | IHME |
| 1.7 (1.37 - 2.12) | 1997 | Modelled | IHME |
| 1.71 (1.37 - 2.14) | 1996 | Modelled | IHME |
| 1.72 (1.37 - 2.17) | 1995 | Modelled | IHME |
| 1.73 (1.38 - 2.17) | 1994 | Modelled | IHME |
| 1.74 (1.39 - 2.19) | 1993 | Modelled | IHME |
| 1.76 (1.40 - 2.21) | 1992 | Modelled | IHME |
| 1.77 (1.41 - 2.24) | 1991 | Modelled | IHME |
| 1.79 (1.42 - 2.26) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 53,582 (42,670 - 67,800) | 1990 | Modelled | IHME |
| 52,391 (41,781 - 66,280) | 1991 | Modelled | IHME |
| 54,569 (43,540 - 68,670) | 1992 | Modelled | IHME |
| 57,130 (45,464 - 71,734) | 1993 | Modelled | IHME |
| 59,583 (47,604 - 74,781) | 1994 | Modelled | IHME |
| 61,543 (49,086 - 77,389) | 1995 | Modelled | IHME |
| 63,033 (50,442 - 78,647) | 1996 | Modelled | IHME |
| 64,516 (51,984 - 80,371) | 1997 | Modelled | IHME |
| 65,795 (52,928 - 81,783) | 1998 | Modelled | IHME |
| 66,998 (53,926 - 83,245) | 1999 | Modelled | IHME |
| 68,905 (55,389 - 85,716) | 2000 | Modelled | IHME |
| 72,015 (57,944 - 89,495) | 2001 | Modelled | IHME |
| 75,709 (61,002 - 93,863) | 2002 | Modelled | IHME |
| 78,535 (63,103 - 98,046) | 2003 | Modelled | IHME |
| 80,601 (64,880 - 100,837) | 2004 | Modelled | IHME |
| 82,732 (66,363 - 103,550) | 2005 | Modelled | IHME |
| 85,066 (68,362 - 106,546) | 2006 | Modelled | IHME |
| 87,677 (70,728 - 109,803) | 2007 | Modelled | IHME |
| 90,245 (72,667 - 113,010) | 2008 | Modelled | IHME |
| 92,656 (74,491 - 116,041) | 2009 | Modelled | IHME |
| 94,839 (75,998 - 119,256) | 2010 | Modelled | IHME |
| 96,817 (77,760 - 121,430) | 2011 | Modelled | IHME |
| 98,606 (79,218 - 123,293) | 2012 | Modelled | IHME |
| 100,125 (80,459 - 125,253) | 2013 | Modelled | IHME |
| 101,667 (81,928 - 126,473) | 2014 | Modelled | IHME |
| 103,397 (83,457 - 128,470) | 2015 | Modelled | IHME |
| 105,933 (85,686 - 132,377) | 2016 | Modelled | IHME |
| 108,892 (87,191 - 136,200) | 2017 | Modelled | IHME |
| 111,593 (89,463 - 139,822) | 2018 | Modelled | IHME |
| 114,314 (91,262 - 143,329) | 2019 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 9.12 (6.15 - 13.20) | 2019 | Modelled | IHME |
| 9.05 (6.09 - 13.20) | 2018 | Modelled | IHME |
| 9 (6.03 - 13.10) | 2017 | Modelled | IHME |
| 8.9 (5.94 - 12.90) | 2016 | Modelled | IHME |
| 8.88 (5.89 - 13) | 2015 | Modelled | IHME |
| 8.72 (5.78 - 12.70) | 2014 | Modelled | IHME |
| 8.49 (5.65 - 12.30) | 2013 | Modelled | IHME |
| 8.19 (5.40 - 11.90) | 2012 | Modelled | IHME |
| 7.99 (5.22 - 11.70) | 2011 | Modelled | IHME |
| 7.97 (5.18 - 11.80) | 2010 | Modelled | IHME |
| 7.97 (5.22 - 12) | 2009 | Modelled | IHME |
| 7.96 (5.24 - 11.90) | 2008 | Modelled | IHME |
| 7.92 (5.15 - 11.80) | 2007 | Modelled | IHME |
| 7.93 (5.14 - 11.90) | 2006 | Modelled | IHME |
| 7.92 (5.12 - 11.80) | 2005 | Modelled | IHME |
| 7.9 (5.08 - 11.80) | 2004 | Modelled | IHME |
| 7.81 (5.03 - 11.60) | 2003 | Modelled | IHME |
| 7.78 (5.04 - 11.50) | 2002 | Modelled | IHME |
| 7.62 (4.91 - 11.10) | 2001 | Modelled | IHME |
| 7.74 (5.03 - 11.30) | 2000 | Modelled | IHME |
| 7.67 (5 - 11.10) | 1999 | Modelled | IHME |
| 7.55 (4.85 - 11) | 1998 | Modelled | IHME |
| 7.6 (4.84 - 11.10) | 1997 | Modelled | IHME |
| 7.56 (4.78 - 11.20) | 1996 | Modelled | IHME |
| 7.56 (4.70 - 11.10) | 1995 | Modelled | IHME |
| 7.21 (4.55 - 10.70) | 1994 | Modelled | IHME |
| 7.04 (4.44 - 10.50) | 1993 | Modelled | IHME |
| 7 (4.34 - 10.60) | 1992 | Modelled | IHME |
| 7.01 (4.24 - 10.60) | 1991 | Modelled | IHME |
| 6.92 (4.14 - 10.60) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 612 (413 - 886) | 2019 | Modelled | IHME |
| 594 (399 - 865) | 2018 | Modelled | IHME |
| 577 (386 - 839) | 2017 | Modelled | IHME |
| 559 (373 - 813) | 2016 | Modelled | IHME |
| 547 (364 - 801) | 2015 | Modelled | IHME |
| 529 (350 - 772) | 2014 | Modelled | IHME |
| 507 (338 - 735) | 2013 | Modelled | IHME |
| 482 (318 - 700) | 2012 | Modelled | IHME |
| 461 (301 - 674) | 2011 | Modelled | IHME |
| 450 (293 - 666) | 2010 | Modelled | IHME |
| 441 (289 - 661) | 2009 | Modelled | IHME |
| 430 (283 - 644) | 2008 | Modelled | IHME |
| 416 (271 - 619) | 2007 | Modelled | IHME |
| 405 (262 - 606) | 2006 | Modelled | IHME |
| 394 (254 - 588) | 2005 | Modelled | IHME |
| 382 (246 - 569) | 2004 | Modelled | IHME |
| 368 (237 - 548) | 2003 | Modelled | IHME |
| 353 (228 - 522) | 2002 | Modelled | IHME |
| 327 (211 - 477) | 2001 | Modelled | IHME |
| 317 (206 - 462) | 2000 | Modelled | IHME |
| 305 (198 - 441) | 1999 | Modelled | IHME |
| 293 (188 - 427) | 1998 | Modelled | IHME |
| 288 (183 - 421) | 1997 | Modelled | IHME |
| 278 (176 - 411) | 1996 | Modelled | IHME |
| 270 (168 - 398) | 1995 | Modelled | IHME |
| 248 (157 - 369) | 1994 | Modelled | IHME |
| 231 (145 - 344) | 1993 | Modelled | IHME |
| 218 (135 - 329) | 1992 | Modelled | IHME |
| 207 (125 - 315) | 1991 | Modelled | IHME |
| 208 (124 - 319) | 1990 | Modelled | IHME |
| 291 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 23 (16 - 31) | 2019 | Modelled | IHME |
| 23 (16 - 31) | 2018 | Modelled | IHME |
| 23 (16 - 31) | 2017 | Modelled | IHME |
| 23 (16 - 31) | 2016 | Modelled | IHME |
| 23 (16 - 31) | 2015 | Modelled | IHME |
| 22 (16 - 30) | 2014 | Modelled | IHME |
| 22 (15 - 30) | 2013 | Modelled | IHME |
| 22 (15 - 30) | 2012 | Modelled | IHME |
| 22 (15 - 30) | 2011 | Modelled | IHME |
| 22 (15 - 29) | 2010 | Modelled | IHME |
| 22 (15 - 29) | 2009 | Modelled | IHME |
| 21 (15 - 29) | 2008 | Modelled | IHME |
| 21 (15 - 29) | 2007 | Modelled | IHME |
| 21 (15 - 29) | 2006 | Modelled | IHME |
| 21 (14 - 29) | 2005 | Modelled | IHME |
| 21 (14 - 28) | 2004 | Modelled | IHME |
| 21 (14 - 28) | 2003 | Modelled | IHME |
| 21 (14 - 28) | 2002 | Modelled | IHME |
| 20 (14 - 28) | 2001 | Modelled | IHME |
| 20 (13 - 28) | 2000 | Modelled | IHME |
| 20 (13 - 28) | 1999 | Modelled | IHME |
| 20 (13 - 28) | 1998 | Modelled | IHME |
| 20 (13 - 28) | 1997 | Modelled | IHME |
| 20 (13 - 28) | 1996 | Modelled | IHME |
| 20 (13 - 28) | 1995 | Modelled | IHME |
| 20 (13 - 28) | 1994 | Modelled | IHME |
| 20 (13 - 28) | 1993 | Modelled | IHME |
| 20 (13 - 28) | 1992 | Modelled | IHME |
| 20 (13 - 28) | 1991 | Modelled | IHME |
| 20 (13 - 28) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.42
(%)
2019, latest modelled
(0.29 - 0.57(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines